Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001628280-25-000237

Options or other derivatives

  • Chief Legal Officer acquired 832,033 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Stimart Tryn Chief Legal Officer 2025-01-01 Grant or award · Share option (right to buy) +832,033 4,106,747 D
Loading xslF345X05/wk-form4_1735937075.xml…